Park SK - Search Results

1

Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.

Olweny EO, Kapur P, Tan YK, Park SK, Adibi M, Cadeddu JA. Olweny EO, et al. Among authors: park sk. Urology. 2013 Mar;81(3):679-84. doi: 10.1016/j.urology.2012.11.026. Epub 2013 Jan 3. Urology. 2013. PMID: 23290141

2

Patient-reported body image and cosmesis outcomes following kidney surgery: comparison of laparoendoscopic single-site, laparoscopic, and open surgery.

Park SK, Olweny EO, Best SL, Tracy CR, Mir SA, Cadeddu JA. Park SK, et al. Eur Urol. 2011 Nov;60(5):1097-104. doi: 10.1016/j.eururo.2011.08.007. Epub 2011 Aug 12. Eur Urol. 2011. PMID: 21856076

3

Intra-operative erythropoietin during laparoscopic partial nephrectomy is not renoprotective.

Olweny EO, Mir SA, Park SK, Tan YK, Faddegon S, Best SL, Gurbuz C, Cadeddu JA. Olweny EO, et al. Among authors: park sk. World J Urol. 2012 Aug;30(4):519-24. doi: 10.1007/s00345-011-0760-6. Epub 2011 Sep 15. World J Urol. 2012. PMID: 21918797

4

Perioperative comparison of robotic assisted laparoendoscopic single-site (LESS) pyeloplasty versus conventional LESS pyeloplasty.

Olweny EO, Park SK, Tan YK, Gurbuz C, Cadeddu JA, Best SL. Olweny EO, et al. Among authors: park sk. Eur Urol. 2012 Feb;61(2):410-4. doi: 10.1016/j.eururo.2011.10.024. Epub 2011 Oct 24. Eur Urol. 2012. PMID: 22036645

5

Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.

Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Olweny EO, et al. Among authors: park sk. Eur Urol. 2012 Jun;61(6):1156-61. doi: 10.1016/j.eururo.2012.01.001. Epub 2012 Jan 10. Eur Urol. 2012. PMID: 22257424

6

Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters.

Best SL, Park SK, Youssef RF, Olweny EO, Tan YK, Trimmer C, Cadeddu JA. Best SL, et al. Among authors: park sk. J Urol. 2012 Apr;187(4):1183-9. doi: 10.1016/j.juro.2011.11.096. Epub 2012 Feb 14. J Urol. 2012. PMID: 22335865

7

Tadalafil for prevention of renal dysfunction secondary to renal ischemia.

Faddegon S, Best SL, Olweny EO, Tan YK, Park SK, Mir SA, Cadeddu JA. Faddegon S, et al. Among authors: park sk. Can J Urol. 2012 Jun;19(3):6274-9. Can J Urol. 2012. PMID: 22704313

8

A comparison of long term renal functional outcomes following partial nephrectomy and radiofrequency ablation.

Faddegon S, Ju T, Olweny EO, Liu Z, Han WK, Yin G, Tan YK, Gahan J, Bedir S, Ma YB, Park SK, Raj GV, Cadeddu JA. Faddegon S, et al. Among authors: park sk. Can J Urol. 2013 Jun;20(3):6785-9. Can J Urol. 2013. PMID: 23783048

9

Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol.

Tan YK, Best SL, Olweny E, Park S, Trimmer C, Cadeddu JA. Tan YK, et al. Urology. 2012 Apr;79(4):827-30. doi: 10.1016/j.urology.2011.12.004. Epub 2012 Feb 4. Urology. 2012. PMID: 22309782

10

In vitro comparison of prototype magnetic tool with conventional nitinol basket for ureteroscopic retrieval of stone fragments rendered paramagnetic with iron oxide microparticles.

Tan YK, McLeroy SL, Faddegon S, Olweny E, Fernandez R, Beardsley H, Gnade B, Park S, Pearle MS, Cadeddu JA. Tan YK, et al. J Urol. 2012 Aug;188(2):648-52. doi: 10.1016/j.juro.2012.03.118. Epub 2012 Jun 15. J Urol. 2012. PMID: 22704446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,962 results

Search Page

Filters